Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin
- PMID: 3120775
- DOI: 10.1016/0167-4838(87)90171-3
Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin
Abstract
To localize the binding region of porcine tissue-type plasminogen activator (EC 3.4.21.31) (t-plasminogen activator) to heparin, functionally active A and B chains (molecular mass of each 33 kDa) were separated from the two-chain t-plasminogen activator after mild reduction and alkylation. The A chain bound to fibrin-Sepharose, but not to heparin-Sepharose. In contrast, the B chain showed amidase activity toward HD-Ile-Pro-Arg-p-nitroanilide (S-2288) and a high affinity for heparin-Sepharose, but no affinity for fibrin-Sepharose. Plasminogen activator activity of the B chain was stimulated by heparin (about 3-fold), but not by fibrin. On the other hand, the elastase digestion fragments of plasminogen, kringle 1-3 and kringle 4, had no affinity for a heparin-Sepharose column, whereas the other fragment, Val442-plasminogen, efficiently bound to the column and was eluted with 1.6 M KSCN-containing buffer. The stimulatory effect of fibrin on two-chain t-plasminogen activator-catalyzed Val442-plasminogen activation was clearly diminished by heparin. These results suggest that heparin can form a complex with both t-plasminogen activator and plasminogen molecules through their catalytic regions located in each B chain, and that the heparin connection between t-plasminogen activator and plasminogen may improve the plasminogen activation kinetics by making a situation in which t-plasminogen activator is easily approachable to plasminogen.
Similar articles
-
Localization of the binding site of tissue-type plasminogen activator to fibrin.J Clin Invest. 1986 Jul;78(1):163-9. doi: 10.1172/JCI112546. J Clin Invest. 1986. PMID: 3088041 Free PMC article.
-
Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.Biochemistry. 1989 Sep 5;28(18):7318-25. doi: 10.1021/bi00444a026. Biochemistry. 1989. PMID: 2510823
-
The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.Protein Eng. 1995 Mar;8(3):293-300. doi: 10.1093/protein/8.3.293. Protein Eng. 1995. PMID: 7479691
-
The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis.Ann N Y Acad Sci. 1992 Dec 4;667:52-63. doi: 10.1111/j.1749-6632.1992.tb51597.x. Ann N Y Acad Sci. 1992. PMID: 1309072 Review. No abstract available.
-
The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator.Biochim Biophys Acta. 1995 Apr 5;1248(1):1-10. doi: 10.1016/0167-4838(94)00230-e. Biochim Biophys Acta. 1995. PMID: 7711052 Review.
Cited by
-
Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.Proc Natl Acad Sci U S A. 1990 Mar;87(5):1865-9. doi: 10.1073/pnas.87.5.1865. Proc Natl Acad Sci U S A. 1990. PMID: 2106684 Free PMC article.
-
Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.Biochem J. 1991 Jun 15;276 ( Pt 3)(Pt 3):785-91. doi: 10.1042/bj2760785. Biochem J. 1991. PMID: 1829607 Free PMC article.
-
Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors.J Med Chem. 2023 Apr 13;66(7):4503-4531. doi: 10.1021/acs.jmedchem.3c00132. Epub 2023 Mar 31. J Med Chem. 2023. PMID: 37001055 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials